AUA: Upper Tract Urothelial Carcinoma (2023): Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
Line 70: | Line 70: | ||
** '''Provides supplemental histologic data to tumor biopsies''' | ** '''Provides supplemental histologic data to tumor biopsies''' | ||
***'''High-grade cytology in the setting of low-grade biopsy findings indicates the likely presence of higher-risk features (e.g., high-grade tumor) missed on biopsy sampling.''' | ***'''High-grade cytology in the setting of low-grade biopsy findings indicates the likely presence of higher-risk features (e.g., high-grade tumor) missed on biopsy sampling.''' | ||
**Urine cytology is reported according to 7 categories (Paris System): | **'''Specimen collection considerations''' | ||
***'''Can be obtained either as barbotage (saline irrigation and aspiration) or by saline irrigation with passive collection (washings)''' | |||
****'''Preferred over a voided urinary specimen''', due to (3) | |||
****#Improve cellular yield | |||
****#Avoid potential contamination in case of concomitant bladder and/or prostatic urethral disease | |||
****#Avoid theoretical dilution of the specimen from a normal contralateral unit | |||
***'''Should be collected prior to any contrast use to avoid artifactual cellular changes from contrast solutions''' | |||
***'''Collecting selective cytology after tumor biopsy can improve the yield of cells for cytologic analysis.''' | |||
**Urine cytology is reported according to 7 categories (Paris System): | |||
**#Non-diagnostic | **#Non-diagnostic | ||
**#Negative for high-grade urothelial carcinoma | **#Negative for high-grade urothelial carcinoma | ||
Line 78: | Line 86: | ||
**#Low-grade urothelial neoplasm | **#Low-grade urothelial neoplasm | ||
**#Other malignancies | **#Other malignancies | ||
*'''<span style="color:#ff0000">Assessment of renal function</span>''' | *'''<span style="color:#ff0000">Assessment of renal function</span>''' | ||
**Initial decisions regarding operative approach and administration of systemic therapy are based on patients’ baseline renal function and their estimated post-operative estimated glomerular filtration rate (eGFR). | **Initial decisions regarding operative approach and administration of systemic therapy are based on patients’ baseline renal function and their estimated post-operative estimated glomerular filtration rate (eGFR). |